Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06073223 · ClinicalTrials.gov registry record · NA
Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
A NA study, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT06073223 is a NA study that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 50 participants.
The verdict
NCT06073223, a NA study, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The study will include 50 patients newly diagnosed with low-risk thyroid cancer ranging from 18-80 years of age. After scheduling their surgeon visit, the investigators will enroll patients and measure their intended treatment choice, baseline awareness of the three treatment options, expected outcomes, self-efficacy, and activation. The participants will then be randomized 1:1 and deliver the CQUPLE intervention to the intervention group. The control group will receive usual care, which involves providing no disease or treatment specific information outside the surgeon visit. The study team will repeat all measures prior to the surgical consult and after the surgical consult. The study team will record the patients' actual treatment choice after the consult.
Interventions
- OTHER Usual Care
- OTHER CQUPLE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-09-18 |
| Est. Completion | 2025-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06073223
The ClinicalTrials.gov registry entry for NCT06073223 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT06073223 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06073223 about?
NCT06073223 is a clinical study titled "Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer". The study will include 50 patients newly diagnosed with low-risk thyroid cancer ranging from 18-80 years of age. After scheduling their surgeon visit, the investigators will enroll patients and measure their intended treatment choice, baseline awareness of the three treatment options, expected outco...
What is the current status of trial NCT06073223?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2023-09-18. Estimated completion is 2025-12-20.
What interventions are being tested in trial NCT06073223?
The interventions under investigation include: Usual Care (OTHER), CQUPLE (OTHER).
Who is sponsoring clinical trial NCT06073223?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.